# Quality of Life of Patients With Glioblastoma (GBM) Treated With Tumor-Treating Fields

> **NCT03501134** · — · COMPLETED · sponsor: **Duke University** · enrollment: 20 (actual)

## Conditions studied

- Malignant Glioma

## Interventions

- **DEVICE:** NovoTTF

## Key facts

- **NCT ID:** NCT03501134
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-08
- **Primary completion:** 2021-06-03
- **Final completion:** 2021-06-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03501134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03501134, "Quality of Life of Patients With Glioblastoma (GBM) Treated With Tumor-Treating Fields". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03501134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*